Source: Virtual Congress 2021 – Therapy of lung cancer



Rating:

Share or cite this content

Citations should be made in the following way:
L. Bitar (Zagreb, Croatia), F. Seiwerth (Zagreb, Croatia), L. Ljubicic (Zagreb, Croatia), A. Bacelic-Gabelica (Zagreb, Croatia), D. Srdic (Zagreb, Croatia), M. Koršic (Zagreb, Croatia), S. Badovinac (Zagreb, Croatia), S. Pleština (Zagreb, Croatia), M. Samaržija (Zagreb, Croatia), M. Jakopovic (Zagreb, Croatia). Survival outcomes of patients diagnosed with lung adenocarcinoma with ALK gene rearrangement. 2312

Member's Comments

No comment yet.

Related content which might interest you: Survival prognosis and target therapy best response in adenocarcinoma lung cancer pts with mutation EGFR gene Source: Annual Congress 2009 - Treatment of lung cancer Year: 2009 Clinical relevance of p53 and K-ras gene mutations in bronchial margins in surgically treated nonsmall cell lung cancer (NSCLC) patients Source: Eur Respir J 2002; 20: Suppl. 38, 230s Year: 2002 A variant in LKB1 gene can predicts the clinical outcomes of chemotherapy in patients with non-small cell lung cancer Source: International Congress 2018 – Lung cancer: new aspects in diagnosis and management Year: 2018 Trends in drug costs and overall survival in patients diagnosed with metastatic non-small cell lung cancer (NSCLC) Source: International Congress 2019 – How to guide patients to reach a balance between costs and personal needs: quality indicators of effectiveness Year: 2019 HER-2/neu overexpression in patients with lung carcinoma Source: Eur Respir J 2003; 22: Suppl. 45, 250s Year: 2003 Prognosis of uncommon metastasis in non-small-cell lung cancer patients with mutated EGFR Source: International Congress 2018 – Lung cancer: modern therapies and beyond Year: 2018 Retrospective study of treatment outcomes according to exon difference with EGFR mutations in non-small cell lung cancer patient in Korea Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012 Positive PD-L1 expression is associated with unfavorable clinical outcome in EGFR-mutated lung adenocarcinomas treated with EGFR-TKIs Source: International Congress 2019 – Treatment of lung cancer Year: 2019 Prognostic implications of smoking in patients with advanced lung adenocarcinoma excluding positive mutations Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 MDM-2 gene amplification is associated with poor prognosis in operable non-small cell lung cancer (NSCLC) Source: Eur Respir J 2002; 20: Suppl. 38, 596s Year: 2002 Interleukine-17A implicated in survival outcome of patients with late stage lung adenocarcinoma Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores Year: 2018 Her/2 neu and p53 expression in patients with non-small cell lung cancer predict shortened survival Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010 ERCC1 expression is a predictor of survival in resected patients with non-small cell lung cancer Source: Annual Congress 2009 - Genetics in the smokers corner: from inflammation in smokers via COPD to cancer Year: 2009 Concordance of p53 and K-ras mutations in induced sputum and corresponding biopsies of patients with nonsmall cell lung cancer (NSCLC) Source: Eur Respir J 2001; 18: Suppl. 33, 18s Year: 2001 Management of EGFR mutated nonsmall cell lung carcinoma patients Source: Eur Respir J 2015; 45: 1132-1141 Year: 2015 Prevalence of ALK translocations in a large cohort of non-small cell cancer patients and quality of hybridization by sampling method. Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside Year: 2017 Survival of elderly small-cell lung cancer patients Source: Annual Congress 2010 - Thoracic malignancies: interesting case studies and series Year: 2010 Comparing exhaled molecular profiles of patients with non-small cell lung cancer (NSCLC) with those of patients with non-pulmonary malignancy Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010 Characteristics and outcome of patients with second primary lung cancer Source: Eur Respir J 2013; 42: 1668-1676 Year: 2013 Long-term prognosis of patients with cancer-related mutations in non-tumoral lung. Source: Virtual Congress 2020 – Biological aspects of lung cancer Year: 2020